perahps he doesn't want to partner bc he is hanging on to rights to tee it up for a buyout
I've never understood biotech boards' enthusiasm for buyouts? For a drug product that is wildly undervalued, buyouts are infrequently the max return - although they are the quickest. OTOH the desire for buyouts seems to occur most frequently when the stock is either substantially underwater or has languished for a very long time.
???????????
BTW - I'll respond to your other post, but it is a well thought out post and so it will take me some time.
Market Data 
Markets 
AI
